BIZTRAC BETA
Manufacture of pharmaceutical preparations

PALLA PHARMA NORWAY HOLDING AS

Org. no. 919610581 Limited company (AS) Kragerø Incorporated 2017 Active
Ownership graph ↗
Operating profit NOK −14,000
Equity NOK 91.0m
Incorporated 2017
Share capital NOK 2.2m

Signals

2 flags
  • Driftsunderskudd 2024 Siste driftsresultat er negativt (−14k kr).
  • Ingen revisor Selskapet har ingen registrert revisor. Vanlig for små AS som har valgt bort revisjon, men verdt å merke seg.

PALLA PHARMA NORWAY HOLDING AS is registered as a limited company in Kragerø, Telemark with organisation number 919610581. The business is classified under manufacture of pharmaceutical preparations (NACE 21.200). The company was incorporated in 2017. Registered share capital is NOK 2.2m, divided into 22289 shares. The company's stated purpose is: “Handel med og investering i fast eiendom, verdipapirer og andre formuesobjekter, herunder deltakelse i andre selskaper med lignende virksomhet.”.

Key figures · 2024

Operating profit
NOK −14,000
Equity
NOK 91.0m
Est. value
NOK 106.9m

Financial health · 2024

Liquidity
0.56
Weak
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
88.8%
Very good
Equity as a share of total capital

Who owns PALLA PHARMA NORWAY HOLDING AS?

MA-INVEST AS
PALLA PHARMA NORWAY HOLDING AS
· NOK −14,000 profit

PALLA PHARMA NORWAY HOLDING AS has 20+ registered shareholders:

All shareholders and roles →

Which companies does PALLA PHARMA NORWAY HOLDING AS own?

PALLA PHARMA NORWAY HOLDING AS holds stakes in 2 companies:

See the full ownership structure →

Frequently asked questions about PALLA PHARMA NORWAY HOLDING AS

Who owns PALLA PHARMA NORWAY HOLDING AS?

MA-INVEST AS is the largest registered owner, with 31.2%.

Where is PALLA PHARMA NORWAY HOLDING AS based?

PALLA PHARMA NORWAY HOLDING AS has its business address in Kragerø.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.